English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1872]
News [4283]
Articles [400]
Editorials [10]
Conferences [107]
elearning [41]
CDK6 a transcriptional regulator in AML
Prof Veronika Sexl - University of Veterinary Medicine of Vienna, Vienna...
CDK6 a transcriptional regulator in AML ( Prof Veronika Sexl - University of Veterinary Medicine of Vienna, Vienna, Austria )
27 Jun 2018
ASCO 2018 conference round up
Dr Bishal Gyawali and Will Davies
ASCO 2018 conference round up ( Dr Bishal Gyawali and Will Davies )
24 Jun 2018
Results from the phase I ICONIC trial
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Results from the phase I ICONIC trial ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
4 Jun 2018
Design and interim safety analysis of GeparX trial
Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany
Design and interim safety analysis of GeparX trial ( Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany )
4 Jun 2018
What does progression-free survival mean for breast cancer patients?
Dr Peter Schmid - Barts Cancer Institute, London, UK
What does progression-free survival mean for breast cancer patients? ( Dr Peter Schmid - Barts Cancer Institute, London, UK )
4 Jun 2018
Finding appropriate doses for HER2 positive breast cancers
Dr Mariana Chavez-MacGregor - MD Anderson Cancer Center, Houston, USA
Finding appropriate doses for HER2 positive breast cancers ( Dr Mariana Chavez-MacGregor - MD Anderson Cancer Center, Houston, USA )
3 Jun 2018
Results from the LILAC study of ABP 980 with trastuzumab for HER2 early breast...
Dr Hans-Christian Kolberg - Marienhospital Bottrop, Bottrop, Germany
Results from the LILAC study of ABP 980 with trastuzumab for HER2  early breast cancer ( Dr Hans-Christian Kolberg - Marienhospital Bottrop, Bottrop, Germany )
3 Jun 2018
Most breast cancer patients could avoid chemo with use of genetic testing
Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
Most breast cancer patients could avoid chemo with use of genetic testing ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )
3 Jun 2018
Comment: Genetic testing of early breast tumours could allow patients to go...
Dr Harold Burstein & Prof Richard Schilsky
Comment: Genetic testing of early breast tumours could allow patients to go without chemo ( Dr Harold Burstein & Prof Richard Schilsky )
3 Jun 2018
Genetic testing of early breast tumours could allow patients to go without chemo
Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
Genetic testing of early breast tumours could allow patients to go without chemo ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )
3 Jun 2018
ASCO 2018: Integrating genomic data throughout treatment for prostate cancer
Prof Kurt Miller and Prof Bertrand Tombal
ASCO 2018: Integrating genomic data throughout treatment for prostate cancer ( Prof Kurt Miller and Prof Bertrand Tombal )
2 Jun 2018
A multi-histology basket trial of ado-trastuzumab emtansine in patients with...
Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA
A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers ( Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA )
2 Jun 2018
<1...6364656667...156>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top